Currently, two lines of research are ongoing in the Helsinki laboratory:
Non-coding genome is a vast resource of regulatory elements utilized by transcription factors to orchestrate cell type- and context-specific gene expression. Cancer cells can hijack and repurpose these elements for activating tumorigenic signaling pathways. Our goal is to understand enhancer reprogramming and malfunction using a plethora of functional genomics methods in several cancer types originating from cells of endodermal lineage.
In this translational project, we are studying the role of defined lineage-specific transcription factors and epigenome reprogramming during cancer progression. Transcriptional and epigenetic features as well as topological constraints in chromatin are systematically analyzed using genome-wide functional genomics methods for better understanding of disease progression and evolution.
The Enhancer Biology group is part of the